Page last updated: 2024-11-04

sibutramine and Porphyria, Variegate

sibutramine has been researched along with Porphyria, Variegate in 1 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Porphyria, Variegate: An autosomal dominant porphyria that is due to a deficiency of protoporphyrinogen oxidase (EC 1.3.3.4) in the LIVER, the seventh enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, COPROPORPHYRINS and protoporphyrinogen.

Research Excerpts

ExcerptRelevanceReference
" We describe the case of a 46-year-old female patient presenting with a first episode of symptomatic porphyria after 10 d of sibutramine treatment for weight loss."7.76Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. ( Eickmann, S; Finckh, U; Haverkamp, T; Reiser, M, 2010)
" We describe the case of a 46-year-old female patient presenting with a first episode of symptomatic porphyria after 10 d of sibutramine treatment for weight loss."3.76Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. ( Eickmann, S; Finckh, U; Haverkamp, T; Reiser, M, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reiser, M1
Eickmann, S1
Haverkamp, T1
Finckh, U1

Other Studies

1 other study available for sibutramine and Porphyria, Variegate

ArticleYear
Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss.
    Obesity reviews : an official journal of the International Association for the Study of Obesity, 2010, Volume: 11, Issue:4

    Topics: Appetite Depressants; Cyclobutanes; Female; Flavoproteins; Genetic Predisposition to Disease; Humans

2010